Insufficient scRNA-seq data for expression of TRIM17 at single-cell level.
Insufficient scRNA-seq data for expression of TRIM17 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 97% | 269.62 | 175 / 180 | 99% | 13.94 | 426 / 430 |
thymus | 94% | 283.49 | 611 / 653 | 71% | 1.81 | 430 / 605 |
brain | 89% | 1340.21 | 2363 / 2642 | 72% | 2.25 | 511 / 705 |
uterus | 84% | 242.27 | 143 / 170 | 69% | 6.37 | 318 / 459 |
lung | 69% | 115.79 | 398 / 578 | 70% | 3.92 | 804 / 1155 |
bladder | 67% | 136.71 | 14 / 21 | 62% | 5.48 | 312 / 504 |
breast | 59% | 254.77 | 269 / 459 | 67% | 3.84 | 744 / 1118 |
prostate | 89% | 366.58 | 217 / 245 | 33% | 0.66 | 165 / 502 |
esophagus | 38% | 66.09 | 547 / 1445 | 79% | 2.48 | 144 / 183 |
kidney | 90% | 212.74 | 80 / 89 | 15% | 0.50 | 134 / 901 |
spleen | 100% | 540.77 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.19 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 86% | 2.48 | 69 / 80 |
skin | 50% | 85.36 | 901 / 1809 | 36% | 1.28 | 170 / 472 |
stomach | 23% | 35.22 | 82 / 359 | 33% | 0.81 | 95 / 286 |
pancreas | 6% | 8.69 | 20 / 328 | 43% | 1.55 | 76 / 178 |
adrenal gland | 38% | 77.26 | 97 / 258 | 10% | 0.20 | 22 / 230 |
intestine | 21% | 27.43 | 202 / 966 | 17% | 0.40 | 87 / 527 |
tonsil | 0% | 0 | 0 / 0 | 29% | 0.87 | 13 / 45 |
adipose | 28% | 75.65 | 343 / 1204 | 0% | 0 | 0 / 0 |
heart | 26% | 43.78 | 228 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 18% | 0.78 | 74 / 406 |
peripheral blood | 15% | 20.27 | 143 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 7% | 11.69 | 94 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.10 | 2 / 29 |
muscle | 0% | 0.37 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032880 | Biological process | regulation of protein localization |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006914 | Biological process | autophagy |
GO_0010468 | Biological process | regulation of gene expression |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0005575 | Cellular component | cellular_component |
GO_0005764 | Cellular component | lysosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | TRIM17 |
Protein name | Tripartite motif-containing 17, isoform CRA_b (cDNA FLJ30864 fis, clone FEBRA2004091, highly similar to Tripartite motif-containing protein 17) E3 ubiquitin-protein ligase TRIM17 (EC 2.3.2.27) (RING finger protein 16) (RING-type E3 ubiquitin transferase TRIM17) (Testis RING finger protein) (Tripartite motif-containing protein 17) Tripartite motif containing 17 |
Synonyms | RBCC hCG_42238 RNF16 TERF |
Description | FUNCTION: E3 ubiquitin ligase that plays important roles in the regulation of neuronal apoptosis, selective autophagy or cell proliferation . Stimulates the degradation of kinetochore ZW10 interacting protein ZWINT in a proteasome-dependent manner, leading to negative regulation of cell proliferation . Inhibits autophagic degradation of diverse known targets while contributing to autophagy of midbodies. Autophagy-inhibitory activity involves MCL1, which TRIM17 assembles into complexes with the key autophagy regulator BECN1 . Controls neuronal apoptosis by mediating ubiquitination and degradation of MCL1 to initiate neuronal death. In addition, regulates NFAT transcription factors NFATC3 and NFATC4 activities by preventing their nuclear localization, thus inhibiting their transcriptional activities. Decreases TRIM41-mediated degradation of ZSCAN2 thereby stimulating alpha-synuclein/SNCA transcription in neuronal cells (By similarity). Prevents the E3 ubiquitin-ligase activity of TRIM28 and its interaction with anti-apoptotic BCL2A1, blocking TRIM28 from ubiquitinating BCL2A1 . . |
Accessions | ENST00000295033.7 [Q9Y577-1] E5RJW6 ENST00000457345.2 B3KP04 J3KNZ3 ENST00000366698.7 [Q9Y577-1] J3KQG0 Q9Y577 E5RI62 ENST00000355586.4 ENST00000456946.6 [Q9Y577-2] ENST00000366697.6 [Q9Y577-1] ENST00000479800.1 ENST00000520264.1 |